MRMD

MariMed Inc.
CAPPED RATING

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

MariMed Inc. (MRMD) is rated C- (2.0/5) on Deltasharpe Prism, scored against General sector peers. Its strongest pillar is Value (C+); its weakest is Momentum (D). The rating has held at C- for 95 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.0 / 5.0
C-
Value
C+
Factor Score 2.6 / 5.0
Growth
C-
Factor Score 1.9 / 5.0
Profitability
C+
Factor Score 2.5 / 5.0
Momentum
D
Factor Score 1.3 / 5.0
Revisions
D+
Factor Score 1.5 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio N/A
EV / EBITDA 16.0
Rev Growth YoY -2.0%
Gross Margin 40.5%
Price Return 3M -13.9%
Price Return 12M -34.0%
Catalyst Signal 0.00
Market Cap N/A
TTM Revenue N/A
Price / Sales 0.7
ROE -1.7%

Historical Factor Score Progression

Held C- for 95 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-07-29 C+ (2.6) C- (1.9) C+ (2.5) D (1.3) D+ (1.5) C- (2.0)
2025-06-30 C+ (2.6) C- (2.0) C+ (2.6) D- (1.1) D+ (1.5) C- (1.9)
2025-03-31 C+ (2.7) C- (2.1) C+ (2.5) D (1.3) D+ (1.5) C- (2.0)
2024-12-31 C+ (2.6) C- (2.1) C (2.2) D (1.3) D (1.5) C- (1.9)
2024-09-30 C+ (2.6) C (2.4) C+ (2.6) D (1.2) D+ (1.5) C- (2.1)
Page 1 of 5